XML 50 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss per Share (Tables)
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following data shows the amounts used in computing net loss per share and the effect on net loss and the weighted-average number of shares (in thousands, except share and per share amounts):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Net loss$(77,686)$(78,046)$(234,588)$(347,947)
Less: Deemed Dividend(4,153)— (4,153)— 
Net loss available to common stockholders$(81,839)$(78,046)$(238,741)$(347,947)
Weighted average shares used in computing net loss per share of Class A and B Common Stock:
Basic15,379,402 172,062 8,707,165 124,538 
Diluted15,379,402 172,062 8,707,165 124,538 
Net loss per share of Class A and B Common Stock attributable to common stockholders:
Basic$(5.32)$(453.59)$(27.42)$(2,793.90)
Diluted$(5.32)$(453.59)$(27.42)$(2,793.90)
Schedule of Antidilutive Shares Excluded From Calculation of Diluted Net Loss Per Share
The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock attributable to Common Stock stockholders because their effect was anti-dilutive:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Shares issuable upon conversion of SPA Notes and settlement of make-whole provisions25,995,784 746,412 25,995,784 746,412 
Shares issuable upon conversion of Unsecured Convertible Notes666,624 — 666,624 — 
Shares issuable upon exercise of SPA Warrants15,143 13,790 15,143 13,790 
Shares issuable upon exercise of Junior SPA Warrants5,931,638 — 5,931,638 — 
Other warrants 1,278,802 34,136 1,278,802 34,136 
Stock-based compensation awards – Options 2,879 3,568 2,879 3,568 
Stock-based compensation awards – RSUs 1,529,966 1,481 1,529,966 1,481 
Public warrants
2,453 2,453 2,453 2,453 
Private warrants12 12 12 12 
Total35,423,301 801,852 35,423,301 801,852